Are you over 18 and want to see adult content?
More Annotations
A complete backup of reveriesunderthesignofausten.wordpress.com
Are you over 18 and want to see adult content?
A complete backup of stichtingargus.nl
Are you over 18 and want to see adult content?
A complete backup of lescritiquesdemarine.com
Are you over 18 and want to see adult content?
A complete backup of weddingvenue-tn.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://918kiss2.com
Are you over 18 and want to see adult content?
A complete backup of https://lebanonohio.gov
Are you over 18 and want to see adult content?
A complete backup of https://intimissimi.it
Are you over 18 and want to see adult content?
A complete backup of https://guavus.com
Are you over 18 and want to see adult content?
A complete backup of https://pavia.com.mk
Are you over 18 and want to see adult content?
A complete backup of https://ububu.ru
Are you over 18 and want to see adult content?
A complete backup of https://huffingtonpost.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://organssos.com
Are you over 18 and want to see adult content?
A complete backup of https://eval.org
Are you over 18 and want to see adult content?
A complete backup of https://ir-ltd.net
Are you over 18 and want to see adult content?
A complete backup of https://referralsoverbreakfast.com
Are you over 18 and want to see adult content?
Text
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT US Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. PATIENTS AS PARTNERS USA A 3-Day Festival of Ideas from Patients, Pharma and FDA on How Patient Engagement and Involvement Gets Done . The 8th annual Patients as Partners was guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how patient involvement gets done throughout the entire AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies &DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
JP MORGAN HEALTHCARE CONFERENCE 2021: WHAT TO EXPECT JP Morgan Healthcare Conference 2021: What to Expect. January 7, 2021. The JPM Healthcare Conference’s 39th annual meeting is coming up (Monday January 11, to Thursday, January 14th) and for the first time in its history, it’ll be virtual. The conference sets the tone for the year to come, and will no doubt take into consideration the PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEW Overview. Partnership Opportunities in Drug Delivery (PODD) is back in person with a hybrid option and promises to uphold its ten year tradition of combining partnering with access to cutting-edge business and scientific content in the field of drug delivery with loyal support from a top notch speaking faculty. PODD offers access to a wide range of drug delivery technologies and opensIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT US Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. PATIENTS AS PARTNERS USA A 3-Day Festival of Ideas from Patients, Pharma and FDA on How Patient Engagement and Involvement Gets Done . The 8th annual Patients as Partners was guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how patient involvement gets done throughout the entire AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies &DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
JP MORGAN HEALTHCARE CONFERENCE 2021: WHAT TO EXPECT JP Morgan Healthcare Conference 2021: What to Expect. January 7, 2021. The JPM Healthcare Conference’s 39th annual meeting is coming up (Monday January 11, to Thursday, January 14th) and for the first time in its history, it’ll be virtual. The conference sets the tone for the year to come, and will no doubt take into consideration the PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEW Overview. Partnership Opportunities in Drug Delivery (PODD) is back in person with a hybrid option and promises to uphold its ten year tradition of combining partnering with access to cutting-edge business and scientific content in the field of drug delivery with loyal support from a top notch speaking faculty. PODD offers access to a wide range of drug delivery technologies and opensIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
THE CONFERENCE FORUM Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series.2021 AGENDA
12:45 pm. Lunch Break & Meet the Sponsors; 1:30 pm. How a Site Embraced New Technologies to Support the 1st Virtual UK Trial in IBS . A clinical site in the UK has embraced digital technology to test a new treatment for patients of irritable bowel syndrome, IO360° IMMUNO-ONCOLOGY CONFERENCE Immuno-Oncology 360° reported on the most current data and rapid advancements to help IO stakeholders: Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy. Foster collaboration amongst those working in all aspects of cancer immunotherapy together under oneroof.
DRUG DELIVERY WEST OVERVIEW Next Frontiers in Drug Delivery. The 3rd annual Drug Delivery West (DDW) Summit provided a west coast venue for biotech, pharma and drug delivery companies that addressed scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care. THE COMPLEX ROLE OF THE CHIEF MEDICAL OFFICER The role of the Chief Medical Officer in emerging biotechs is a complex one, requiring balancing responsibilities both internally as the primary decision-maker when it comes to scientific interpretation and patient safety and externally as the company’s public medical representative. “We have one of the most challenging roles in thecompany.
OFFICIAL CONFERENCE GUIDE May 16-17, 2022 | San Francisco, CA MICHELLE TARVER, MD, PHD Michelle Tarver, MD, PhD, is the Director of Patient Science and Engagement at the Center for Devices and Radiological Health (CDRH). She attended Spelman College in Atlanta, GA where she received a BS in biochemistry. She completed the MD/PhD program at The Johns Hopkins University Bloomberg School of Public Health in 2002 earning her ROBYN BENT | THE CONFERENCE FORUM Robyn Bent joined the US FDA in 2019 as the director of the Center for Drug Evaluation and Research (CDER) Patient-Focused Drug Development (PFDD) Initiative, an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making.ANDREA NECCHI, MD
Professor Andrea Necchi is a medical oncologist specialized in the treatment of urological malignancies. He received his medical degree at the University of Milan, Italy, and subsequently he completed the post-doc specialization in medical oncology at the same University. Prof. Necchi’s activity is fully dedicated to the treatment ofKATIE LAPINS
Katie Lapins – Government Pricing Specialists, LLC Catrina Hirschauer – Upsher-Smith Laboratories , Inc. Government PricingBasics Katie Lapins
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT US Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies &DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PATIENTS AS PARTNERS USA A 3-Day Festival of Ideas from Patients, Pharma and FDA on How Patient Engagement and Involvement Gets Done . The 8th annual Patients as Partners was guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how patient involvement gets done throughout the entire PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEW Overview. Partnership Opportunities in Drug Delivery (PODD) is back in person with a hybrid option and promises to uphold its ten year tradition of combining partnering with access to cutting-edge business and scientific content in the field of drug delivery with loyal support from a top notch speaking faculty. PODD offers access to a wide range of drug delivery technologies and opens DDW: DRUG DELIVERY WEST 2021 AGENDA DDW: DRUG DELIVERY WEST 2021 WWW.DRUGDELIVERYWEST.ORG AGENDA 3 DAY TWO - TUESDAY MAY 18 , 2021 8:30 am DDW Virtual Stage Opens This is an opportunity to explore the platform, reach out to fellow THE COMPLEX ROLE OF THE CHIEF MEDICAL OFFICER The role of the Chief Medical Officer in emerging biotechs is a complex one, requiring balancing responsibilities both internally as the primary decision-maker when it comes to scientific interpretation and patient safety and externally as the company’s public medical representative. “We have one of the most challenging roles in thecompany.
IRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT US Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies &DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PATIENTS AS PARTNERS USA A 3-Day Festival of Ideas from Patients, Pharma and FDA on How Patient Engagement and Involvement Gets Done . The 8th annual Patients as Partners was guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how patient involvement gets done throughout the entire PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEW Overview. Partnership Opportunities in Drug Delivery (PODD) is back in person with a hybrid option and promises to uphold its ten year tradition of combining partnering with access to cutting-edge business and scientific content in the field of drug delivery with loyal support from a top notch speaking faculty. PODD offers access to a wide range of drug delivery technologies and opens DDW: DRUG DELIVERY WEST 2021 AGENDA DDW: DRUG DELIVERY WEST 2021 WWW.DRUGDELIVERYWEST.ORG AGENDA 3 DAY TWO - TUESDAY MAY 18 , 2021 8:30 am DDW Virtual Stage Opens This is an opportunity to explore the platform, reach out to fellow THE COMPLEX ROLE OF THE CHIEF MEDICAL OFFICER The role of the Chief Medical Officer in emerging biotechs is a complex one, requiring balancing responsibilities both internally as the primary decision-maker when it comes to scientific interpretation and patient safety and externally as the company’s public medical representative. “We have one of the most challenging roles in thecompany.
IRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
NEWS | THE CONFERENCE FORUM The Conference Forum announced that the Patients as Partners conference is collaborating with the Patient Data Access Initiative (PDAI) in presenting a webinar series on best practices and guidelines for providing patients with appropriate access to their clinical trial data. The four-part webinar series will kick off March 25, 2021.2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option.2021 AGENDA
12:45 pm. Lunch Break & Meet the Sponsors; 1:30 pm. How a Site Embraced New Technologies to Support the 1st Virtual UK Trial in IBS . A clinical site in the UK has embraced digital technology to test a new treatment for patients of irritable bowel syndrome, THECONFERENCEFORUM.ORG theconferenceforum.org DRUG DELIVERY WEST OVERVIEW Next Frontiers in Drug Delivery. The 3rd annual Drug Delivery West (DDW) Summit provided a west coast venue for biotech, pharma and drug delivery companies that addressed scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care.KRISTIN BLOUCH
Patients as Partners Speakers Kristin Blouch Head, Molecular Disease Characterization & Stragegy GSK. Kristin Blouch is leading a novel Molecular Disease Characterization program that provides new opportunities to benefit cancer research and patient empowerment.YULEI WANG, PHD
Yulei Wang, PhD is a Principal Scientist in the Cancer Immunotherapy Biomarker Group at Genentech. She is the team leader for biomarker studies in HCC clinical trials, as well as translational and reverse translational research in the HCC disease area. By integrating cancer genomics, digital pathology, ctDNA and single cell multi-omics in OFFICIAL CONFERENCE GUIDE May 16-17, 2022 | San Francisco, CA 5TH ANNUAL GLOBAL CLINICAL TRIALS PRESENTING COMPANIES Crafting a global development strategy 5th Annual Global Clinical Trials GCT SEPTEMBER 10, 2014 FAIRMONT COPLEY PLAZA, BOSTON, MA Executive Sponsors Organized by REGISTER AT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580 Lori Abrams BONA FIDE SERVICE FEES & FAIR MARKET VALUE Bona Fide Services Fees & Fair Market Value 4-Part Test under Medicaid 4-part test in Final DRA Rule remains applicable to BP 2012 AMP Proposed Rule would extend/ continue use of 4-part test for AMP as well 1. Paid by a Manufacturer to an EntityTHE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies & PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
REGISTRATION FEES
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies & PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
REGISTRATION FEES
THE CONFERENCE FORUM Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series.CONFERENCES
Philadelphia, PA March 14-15, 2022. The only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Government. Learn More ». NEWS | THE CONFERENCE FORUM The Conference Forum announced that the Patients as Partners conference is collaborating with the Patient Data Access Initiative (PDAI) in presenting a webinar series on best practices and guidelines for providing patients with appropriate access to their clinical trial data. The four-part webinar series will kick off March 25, 2021. NOW AVAILABLE: 2021 IO360° RECAP NEWSLETTER June 1, 2021 . We are pleased to share highlights of the keynote presentations from the 7th annual Immuno-Oncology 360° program alongwith a recap of
MEDINCELL | THE CONFERENCE FORUM MedinCell is a clinical stage pharmaceutical company developing long acting injectables with BEPO®, its game-changing technology platform enabling controlled, localized and sustained drug delivery.2020 SPONSORS
2020 Supporting Sponsors. BioTel is a pioneering core lab for clinical trials, an innovative medical device company, and a leading healthcare services organization. With these unique competencies, we have built our research expertise working with Sponsors, CROs and sites, conducting more than 2,000 clinical trials. DRUG DELIVERY WEST OVERVIEW Next Frontiers in Drug Delivery. The 3rd annual Drug Delivery West (DDW) Summit provided a west coast venue for biotech, pharma and drug delivery companies that addressed scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care. BIOGRAIL | THE CONFERENCE FORUM Biograil is pre-clinical stage company using its unique experience in combining device technology with oral drug delivery. The team led the R&D of the world’s first commercial injection molded tablet to be approved by the FDA and commercialized in the US. VERILY | THE CONFERENCE FORUM To learn more, visit. Save The Date! September 28-29, 2021 The Westin Boston Seaport District | Boston, MA. Questions? Call 646-350-2580 THECONFERENCEFORUM.ORG theconferenceforum.orgTHE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies & PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
REGISTRATION FEES
THE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series. OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO. At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options. Demonstrate practical examples, strategies and success stories fromhealth
DPHARM OVERVIEW
DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patientfeedback.
2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. AGENDA | THE CONFERENCE FORUM Examples of technologies presented: enabling injectable systems, needle-free devices, nanoparticle platforms, subcutaneous formulations, oral delivery systems, and connected health platforms. These are “quick fire” presentations, with Q&A following each presentation. Breakout 1A: Device Technologies & PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to: The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas into action. Set against the backdrop of COVID-19 and the new normal in clinical research, the program highlighted the critical need toinvolve patients
PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWIRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the ‘Single Point of Accountability’ for BLENREP© (belantamab mafodotin, anti-BCMA ADC). She leads a cross-discipline Medicine Development Team andcollaborates with
REGISTRATION FEES
THE CONFERENCE FORUM Save the Date for the 8th annual Mobile in Clinical Trials on September 27, 2021. Enjoy our latest webinars on leadership, technology, and patient engagement. We are expanding our life science research editorial offerings to include quarterly newsletters, conference recaps and profile series.CONFERENCES
Philadelphia, PA March 14-15, 2022. The only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Government. Learn More ». NEWS | THE CONFERENCE FORUM The Conference Forum announced that the Patients as Partners conference is collaborating with the Patient Data Access Initiative (PDAI) in presenting a webinar series on best practices and guidelines for providing patients with appropriate access to their clinical trial data. The four-part webinar series will kick off March 25, 2021. NOW AVAILABLE: 2021 IO360° RECAP NEWSLETTER June 1, 2021 . We are pleased to share highlights of the keynote presentations from the 7th annual Immuno-Oncology 360° program alongwith a recap of
MEDINCELL | THE CONFERENCE FORUM MedinCell is a clinical stage pharmaceutical company developing long acting injectables with BEPO®, its game-changing technology platform enabling controlled, localized and sustained drug delivery.2020 SPONSORS
2020 Supporting Sponsors. BioTel is a pioneering core lab for clinical trials, an innovative medical device company, and a leading healthcare services organization. With these unique competencies, we have built our research expertise working with Sponsors, CROs and sites, conducting more than 2,000 clinical trials. DRUG DELIVERY WEST OVERVIEW Next Frontiers in Drug Delivery. The 3rd annual Drug Delivery West (DDW) Summit provided a west coast venue for biotech, pharma and drug delivery companies that addressed scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care. BIOGRAIL | THE CONFERENCE FORUM Biograil is pre-clinical stage company using its unique experience in combining device technology with oral drug delivery. The team led the R&D of the world’s first commercial injection molded tablet to be approved by the FDA and commercialized in the US. VERILY | THE CONFERENCE FORUM To learn more, visit. Save The Date! September 28-29, 2021 The Westin Boston Seaport District | Boston, MA. Questions? Call 646-350-2580 THECONFERENCEFORUM.ORG theconferenceforum.orgTHE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics topatients faster.
OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO . At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options.DPHARM OVERVIEW
Overview . DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians.2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to:. The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas intoaction.
AGENDA | THE CONFERENCE FORUM Presenting Companies: Smart Autoinjector, Meeting Future Injection Needs – Today . Although single use disposable autoinjectors have become the gold standard for self-administration of drugs to treat chronic diseases, market trends around sustainability, performance and connectivity point towards the need for a PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWREGISTRATION FEES
IRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the 'Single Point ofTHE CONFERENCE
FORUMCONFERENCESADVISORSNEWSPHARMATALKRADIO/WEBINARSABOUT USCONTACT USTHE CONFERENCE BOARDTHE CONFERENCE EXAMTHE CONFERENCE BOARD FUNERAL SERVICETHE CONFERENCE BOARD MEMBERSHIP COSTTHE CONFERENCE FUNERALSERVICE EXAM
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics topatients faster.
OVERVIEW | THE CONFERENCE FORUM 5 Goals of CRAACO . At the annual Conference and throughout the year, CRAACO aims to: Bring together a variety of health systems, pharma, patient advocacy, payors, regulators and innovators to chart a path forward integrating clinical care with clinical research options.DPHARM OVERVIEW
Overview . DPHARM is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians.2021 AGENDA
Case Study #3. 4:00 pm ET – 4:20 pm ET. How Gilead Addresses Diversity, Inclusion and Equity in Breast Cancer Clinical Research. In this session, Gilead’s Jeanette Meibach and Michele O’Brien will share how in collaboration with Public Affairs, Medical Affairs and Patient Engagement, a working group was established to understand perspectives from clinicians, industry partners and2021 AGENDA
2021 Agenda *All session times are in Eastern Standard Time. 8:15 am. CRAACO Virtual Platform Opens. This is an opportunity to explore the platform, reach out to fellow attendees and visit the technology and service companies working specifically in the integration of clinical research as a care option. PATIENTS EUROPE 2020 Patients as Partners EU is the first European event dedicated to:. The 2021 program was co-produced with industry, patient advocacy and public sector voices, providing the know-how to turn ideas intoaction.
AGENDA | THE CONFERENCE FORUM Presenting Companies: Smart Autoinjector, Meeting Future Injection Needs – Today . Although single use disposable autoinjectors have become the gold standard for self-administration of drugs to treat chronic diseases, market trends around sustainability, performance and connectivity point towards the need for a PARTNERSHIP OPPORTUNITIES IN DRUG DELIVERY OVERVIEWREGISTRATION FEES
IRA GUPTA, MD
Ira Gupta, MD is currently Vice President, Medicines Development Leader – Global Oncology Therapy Area, at GlaxoSmithKline. As the Medicine Development Leader, Dr Gupta has the 'Single Point of THE CONFERENCE FORUM The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics topatients faster.
CONFERENCES
San Francisco, CA May 16-17, 2022. This west coast event is for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to NOW AVAILABLE: 2021 IO360° RECAP NEWSLETTER June 1, 2021 . We are pleased to share highlights of the keynote presentations from the 7th annual Immuno-Oncology 360° program alongwith a recap of
NEWS | THE CONFERENCE FORUM Fred Hassan On Digital Transformation for Companies: A Journey, Not Just a Destination. May 26, 2021. We are pleased to share a recent interview with Fred Hassan, Director, Warburg Pincus and R&D Leadership Summit advisor in PharmExec, discuss the key considerations Fortune 500 C-suites should make as they position their firms from pilots to enterprise-wide digital transformation. MEDINCELL | THE CONFERENCE FORUM MedinCell is a clinical stage pharmaceutical company developing long acting injectables with BEPO®, its game-changing technology platform enabling controlled, localized and sustained drug delivery. BIOGRAIL | THE CONFERENCE FORUM Biograil is pre-clinical stage company using its unique experience in combining device technology with oral drug delivery. The team led the R&D of the world’s first commercial injection molded tablet to be approved by the FDA and commercialized in the US. VERILY | THE CONFERENCE FORUM To learn more, visit. Save The Date! September 28-29, 2021 The Westin Boston Seaport District | Boston, MA. Questions? Call 646-350-2580 IO360° IMMUNO-ONCOLOGY CONFERENCE Immuno-Oncology 360° (February 23-26, 2021, Virtual) comprehensively addresses key aspects from all facets of IO, from scientific and clinical to business. DRUG DELIVERY WEST OVERVIEW Next Frontiers in Drug Delivery. The 3rd annual Drug Delivery West (DDW) Summit provided a west coast venue for biotech, pharma and drug delivery companies that addressed scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care.2020 SPONSORS
IQVIA is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help View Mobile Friendly Conference List » Setting new standards in information exchange for the pharmaceutical and biotech industry.QUESTIONS?_ CALL 646-350-2580_Menu
* Home
* Conferences
* Patients as Partners Europe * Cell and Gene Therapy Day * Immuno-Oncology 360° * Patients as Partners * Drug Delivery West * IO Combinations 360° * R&D Leadership Summit * Mobile in Clinical Trials * DPharm: Disruptive Innovations US * PODD: Partnerships in Drug Delivery * Chief Medical Officer Summit 360˚ * Clinical Research as a Care Option* Advisors
* News
* PharmaTalkRadio/Webinars * PharmaTalkRadio Podcasts * PharmaTalk Webinars* About Us
* About Us
* Affiliations
* American Heart Association* CISCRP
* Greater Gift
* SITC
* FAQs
* Scholarships
* Careers
* Videos
* Contact Us
* How to Get Involved* Sponsorship
* Media
*
The latest immuno-oncology data spanning the science, business and clinical communities will be reported on FEBRUARY 23-26, 2021VIRTUALLY.
Learn More »
*
We are expanding our life science research editorial offerings to include QUARTERLY NEWSLETTERS, conference recaps and profile series.Read more>>
*
Congratulations to the DPharm Idol Disrupt 2020 Winner, King-DevickTechnologies.
Learn More »
*
Clinical Research as a Care Option reports on challenges to bridging the gap between care and research on NOVEMBER 4-6, 2020.Learn More »
*
Looking forward to presenting Patients as Partners Europe virtually JANUARY 25-26, 2021.Learn More »
*
The latest immuno-oncology data spanning the science, business and clinical communities will be reported on FEBRUARY 23-26, 2021VIRTUALLY.
Learn More »
*
We are expanding our life science research editorial offerings to include QUARTERLY NEWSLETTERS, conference recaps and profile series.Read more>>
*
*
*
*
*
*
TESTIMONIALS
* “
This was a terrific event. Congratulations and thanks to the organizers for a worthwhile and informative event.” - MEETA CHATTERJEE, PHD, Legend Biotech, Inc.* “
Wow! What a great event. So many interesting people and CRAACO is such a brilliant movement. I am inspired by so many of the people and presentations that I saw. Congrats...bringing together amazing people at conferences with a mission.” - DAVE BJORK, Patient Advocate* “
Great occasion to group pharmas real needs and their future vision.” - MOMOKA ONODA, Terumo Corp* “
Good variety of topics. I learned about new initiatives, new vocabulary, new groups/sponsors that I can share with mycolleagues.”
- JACQUELINE COLE, Eli Lilly* “
Great job! I've really enjoyed the topics and speakers. All were very relevant and well chosen.” - NISHA DATTA, Duke Clinical Research Institute* “
A terrific conference. I learned a tremendous amount about innovative approaches in the industry and challenges we need to address to take advantage of the opportunities to improve clinical trials.” - LEANNE MADRE, JD, MHA, Clinical Trials Transformation Initiative* “
Congrats on a fantastic conference! I think I can speak for the other advisors in stating that you all created a great gathering with some poignant moments.” - ZEN CHU, MIT Health Sciences & Technology* “
So thankful to The Conference Forum for always prioritizing thepatient voice.”
- LILLY STAIRS, Patient Advocate, Savvy Cooperative* “
This has been the best and smoothest virtual conference experience -phenomenal job!!”
- BARBARA LUECKEL, PHD, Roche* 9
* 8
* 7
* 6
* 5
* 4
* 3
* 2
* 1
*
NEWS & VIDEOS
11/24
Medable, DPHARM Idol 2018 Winner, Raises $91 million in a New Roundof Financing
In a new round of funding,... Read More »11/06
A Hodgkin Lymphoma Patient Discusses the Phase I Clinical Trial thatSaved Her Life
In this podcast,... Read More » Prostate Cancer Survivor, Al Samuels, Tells His Story of How a Clinical Trial Saved His Life For the latest blog posts click here »*
AFFILIATIONS
*
*
*
*
*
*
View All »
GET INVOLVED
*
SPEAK: Participating as a speaker or panelist provides great experience and adds to your professional skills as an industry insider, leader and expert.Learn More »
*
SPONSOR: Giving impeccable service and listening to what you want to achieve is just the start when welcoming you as a Sponsor orExhibitor.
Learn More »
*
MEDIA: To get involved as Press or a Media Partner please contactCustomer Service.
Learn More »
Home | Conferences | Advisors | News | About Us | Contact Us Privacy Policy | Terms and Conditions 2020 The Conference Forum*
Follow Us:
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0